PAA 4.88% 19.5¢ pharmaust limited

New 52 Week High, page-24

  1. 11,748 Posts.
    lightbulb Created with Sketch. 5949

    Global 70 kDa Ribosomal Protein S6 Kinase Market 2019 – ArQule, Inc., Astex Pharmaceuticals Inc, Eddingpharm, Merck KGaA, PharmAust Limited


    Report contains wide array of statistical surveying of 70 kDa Ribosomal Protein S6 Kinase Market which enable clients to break down the future scenario and foresee correct implementation. The data is based on the precise investigation of authentic data of 70 kDa Ribosomal Protein S6 Kinase market. It has included constraints and drivers after the complete analysis of this market. It is made by taking into consideration about its basic data across the world.

    Our expertise has assessed the market with pin-point analysis of key players worldwide,
    ArQule, Inc.
    Astex Pharmaceuticals Inc
    Eddingpharm
    Merck KGaA
    PharmAust Limited
    Phoenix Biotechnology, Inc.
    Sentinel Oncology Limited

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.010(4.88%)
Mkt cap ! $77.20M
Open High Low Value Volume
19.5¢ 19.5¢ 18.8¢ $342.8K 1.779M

Buyers (Bids)

No. Vol. Price($)
2 52999 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 421000 3
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.